Pharmaceutical

ODM-212 by Orion for Solid Tumor: Likelihood of Approval

ODM-212 is under clinical development by Orion and currently in Phase I for Solid Tumor.

Dec 26, 2023 - 18:00
ODM-212 is under clinical development by Orion and currently in Phase I for Solid Tumor.
Read the original article

Tags:

Previous Article

RO-7566802 by Genentech USA for Solid Tumor: Likelihood of Approval

Next Article

KB-707 by Krystal Biotech for Solid Tumor: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Selvita and the University of Oxford join forces to tackle Parkinson’s disease

Selvita and the University of Oxford join forces to tac...

Jun 5, 2023

Opinion: The IRA’s nonsensical distinction between small- and large-molecule drugs

Opinion: The IRA’s nonsensical distinction between smal...

May 9, 2023

MHRA approves GSK’s RSV vaccine for older adults in the UK

MHRA approves GSK’s RSV vaccine for older adults in the UK

Jul 11, 2023